GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (XTER:PA8) » Definitions » Net Income (Continuing Operations)

Paion Ag (XTER:PA8) Net Income (Continuing Operations) : €-19.86 Mil (TTM As of Jun. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Paion Ag Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Paion Ag's Net Income (Continuing Operations) for the six months ended in Jun. 2023 was €-9.62 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2023 was €-19.86 Mil.


Paion Ag Net Income (Continuing Operations) Historical Data

The historical data trend for Paion Ag's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag Net Income (Continuing Operations) Chart

Paion Ag Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.94 -7.02 2.22 -21.79 -0.58

Paion Ag Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.44 -11.35 9.66 -10.24 -9.62

Paion Ag Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-19.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paion Ag  (XTER:PA8) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Paion Ag Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Paion Ag's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Paion Ag (XTER:PA8) Business Description

Industry
Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Executives
Gregor Siebert Board of Directors
Dr. James Neil Phillips Board of Directors

Paion Ag (XTER:PA8) Headlines

No Headlines